中文名称:利福布丁
  • 利福布汀; 4-N-异丁基螺哌啶利福霉素 S; 4-脱氧-3,4-[2-螺(N-异丁基-4-哌啶基)]-(1H)-咪唑并-(2,5-双氢)利福霉素S; 螺哌啶利福霉素S
  • Rifabutin
  • 4-N-ISOBUTYLSPIROPIPERIDYLRIFAMYCIN S; RIFABUTINE; 1,4-dihydro-1-deoxy-1’,4-didehydro-5’-(2-methylpropyl)-1-oxo-rifamycinxi; 1,4-dihydro-1-deoxy-1’,4-didehydro-5’-(2-methylpropyl)-1-oxorifamycinxiv; 1’,4-Didehydro-1-deoxy-1,4-dihydro-5’-(2-methylpropyl)-1-oxo-; 4-deoxo-3,4-(2-spiro(n-isobutyl-4-piperidyl)-2,5-dihydro-1h-imidazo)-rifamyc; Ansamycin; (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl acetate
  • 72559-06-9
  • C46H62N4O11
  • 847.0047
  • InChI=1/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1
  • 利福布丁 72559-06-9
  • 1.339g/cm3
  • 969.589°C at 760 mmHg
  • 540.188°C
  • 0mmHg at 25°C
  • 紫红色结晶性粉末。极易溶于氯仿,溶于甲醇,微溶于乙醇,极微溶于水。UV最大吸收(甲醇):493,315,274,238nm。

  • 利福霉素衍生物,有抗利福平耐药结核菌株的作用。所需浓度仅为利福平的1/40。毒性小于利福平。日本将其用于非典型结核菌感染的治疗。对耐药麻风病也有效。预防艾滋病人鸟结核分枝杆菌感染。